LONDON, March 24, 2026, 13:47 GMT
Beazley shares held steady at 1,264 pence as of 1327 GMT on Tuesday, with the price unchanged. Latest takeover disclosures came through, revealing some notable investor moves as Zurich Insurance’s £8.1 billion bid advances. Vanguard surfaced with a 5.03% stake, and D.E. Shaw flagged a 1.62% position via derivatives.
That’s relevant right now because Beazley shares have been trading ex-dividend since March 19, so anyone buying in at this point misses out on the additional 25 pence payment. The more apples-to-apples figure for Zurich’s offer is the 1,310 pence in cash, not the headline 1,335 pence. With Beazley’s stock at 1,264 pence, that puts the shares about 46 pence, or 3.5%, under the cash bid. The spread points to investors still weighing both time and execution risk.
Beazley shareholders are set to receive 1,335 pence per share under the terms announced March 2—1,310 pence in cash along with a 25 pence interim dividend. The scheme document, which is the required circular for a UK court-sanctioned takeover, must be published within 28 days of the announcement unless the Takeover Panel grants an extension. Shareholder votes are anticipated in April, with the deal expected to complete in the second half of 2026, pending regulatory and antitrust sign-off.
Vanguard’s filing on Tuesday disclosed a stake of 30.13 million Beazley shares, equal to 5.03%. The fund manager bought 17,357 shares and offloaded 19,620 on March 23. These Rule 8 forms, standard during offer periods, are triggered for investors holding at least 1% of the relevant stock.
D.E. Shaw, in its own filing, reported exposure to 9.75 million shares—1.62%—using cash-settled derivatives, which mirror the stock’s movement but don’t involve direct ownership. J.P. Morgan Markets, serving as Beazley’s corporate broker and financial adviser, reported having no position.
Zurich has addressed a key question up front: how to pay for Beazley. The Swiss insurance group outlined plans to use around $3 billion in cash on hand, take on $2.9 billion in fresh debt, and raise $5 billion in equity to fund the deal. Reuters noted Zurich wrapped up a 3.9 billion Swiss franc share sale on March 3.
Beazley’s annual pretax profit fell 19%—a decline the company chalked up to weaker pricing and a drag in cyber insurance growth. The Middle East conflict hadn’t caused any significant impact at that stage, according to Beazley. Zurich’s offer landed right before these results, offering investors another angle on what Zurich is taking over.
The deal has kept attention fixed on London-listed specialty insurers like Hiscox and Lancashire. Back in February, Reuters noted analysts flagging further merger potential in the sector: Moody’s Ratings’ Salman Siddiqui pointed out that softer pricing “sets the stage for a multi-year consolidation cycle.” Meanwhile, RBC’s Ben Cohen said buyers are looking to future-proof business models. Reuters
Zurich CEO Mario Greco, speaking on March 2, said the merger would produce the “world’s leading Specialty underwriter,” putting the combined specialty gross written premiums around $15 billion—industry jargon for total premiums collected before subtracting claims and reinsurance. In practice, it means Zurich gains heft in tough-to-insure sectors like cyber, marine, aviation, space, and fine art. Reuters
The gap remains. Court approval, a shareholder vote, and a full slate of regulatory and antitrust signoffs are still required for the transaction. Any holdup in the timeline or the approvals process has the potential to push Beazley’s market price further away from Zurich’s cash offer.
